Intellectual Property,
Health Care, Pharmaceuticals, Biotech,
9th U.S. Circuit Court of Appeals
Jan. 6, 2020
Drug makers ask 9th Circuit to block new state law on generics
The law, AB 824, bans so-called “pay-to-delay” deals that can keep generic versions of drugs off the market.
A pharmaceutical industry group has asked the 9th U.S. Circuit Court of Appeal to block a new California law on generic drugs while its legal challenge plays out.
On New Year's Eve, U.S. District Court Judge Troy L. Nunley declined to block AB 824. The law bans so-called "pay-to-delay" deals that can keep generic versions of drugs off the market.
Or access this article for $45
Already a subscriber?
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Sign In
Enewsletter Sign-up
